Inserm Transfert Initiative

Inserm Transfert Initiative

FinSMEs

Pfizer Acquires Clinical-Stage Biotech Company Therachon, for Up To $810M

$60,000,000 Venture capital (Series B)
FinSMEs

Biotech Company Therachon Raises $60M Mezzanine Financing

Funding Health
$15,000,000 Venture capital (Series A)
FinSMEs

Biomodex Raises $15M in Series A Funding

Funding
£40,000,000 Venture capital (Series B)
PE HUB , FinSMEs

ENYO Pharma raises 40 mln pounds

Funding Health Science

Biomodex, 12 millions d’euros pour mettre l’impression 3D au service des chirurgiens

$5,000,000 Venture capital (Series A)
Therachon

Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing

€22,000,000 Venture capital (Series A)
FinSMEs

Enyo Pharma Secures €22M Series A Financing

Health Funding
$35,000,000 Venture capital (Series A)
businesswire

Therachon Secures $35 Million Financing | Business Wire